| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/08/2011 | US20110218208 2-heterocyclylaminoalkyl-(p-quinone) derivatives for treatment of oxidative stress diseases |
| 09/08/2011 | US20110218207 Isotopically enriched arylsulfonamide ccr3 antagonists |
| 09/08/2011 | US20110218206 Individual and combination of mdivi-1 and nutlin-3 for topical or intravitreal ophthalmic use |
| 09/08/2011 | US20110218205 Piperazine derivatives |
| 09/08/2011 | US20110218204 Pharmaceutically acceptable salts of novel betulinic acid derivatives |
| 09/08/2011 | US20110218203 Treatment of rheumatoid arthritis with a combination of laquinimod and methotrexate |
| 09/08/2011 | US20110218202 Soluble guanylate cyclase activators |
| 09/08/2011 | US20110218201 Novel pyrazolone-derivatives and their use as pde-4 inhibitors |
| 09/08/2011 | US20110218200 Methods of treating amyloid disease using analogs of 1-(4-nitrophenyl) piperazine |
| 09/08/2011 | US20110218199 Pyridoneamide derivatives, their manufacture and use as pharmaceutical agents |
| 09/08/2011 | US20110218198 Pyrrolopyridinylpyrimidin-2-ylamine derivatives |
| 09/08/2011 | US20110218197 Substituted aza-bicyclic imidazole derivatives useful as trpm8 receptor modulators |
| 09/08/2011 | US20110218196 Compounds of estrogen-related receptor modulators and the uses thereof |
| 09/08/2011 | US20110218195 Methods and compositions for treating bacterial infections and diseases associated therewith |
| 09/08/2011 | US20110218194 Heterocyclic aspartyl protease inhibitors |
| 09/08/2011 | US20110218193 Novel tricyclic derivative or pharmaceutically acceptable salts thereof, preparation method thereof, and pharmaceutical composition containing the same |
| 09/08/2011 | US20110218192 Inhibitors Of Beta-Secretase |
| 09/08/2011 | US20110218191 Use of meloxicam for the long term-treatment of kidney disorders in cats |
| 09/08/2011 | US20110218190 Therapeutic uses of ampa receptor modulators for treatment of motor dysfunction |
| 09/08/2011 | US20110218189 PYRROLO[2,3-d]PYRIMIDIN-2-YL-AMINE DERIVATIVES AS PKC-THETA INHIBITORS |
| 09/08/2011 | US20110218188 Substituted (pyridyl)-azinylamine derivatives as fungicides |
| 09/08/2011 | US20110218187 Inhibitors of tyrosine kinases |
| 09/08/2011 | US20110218186 Spirocyclic heterocyclic derivatives and methods of their use |
| 09/08/2011 | US20110218185 Azolotriazinone melanin concentrating hormone receptor-1 antagonists |
| 09/08/2011 | US20110218184 Quinolone analogs and methods related thereto |
| 09/08/2011 | US20110218183 Fused Bicyclic mTOR Inhibitors |
| 09/08/2011 | US20110218182 Chemical compounds 251 |
| 09/08/2011 | US20110218181 Formulations of deoxycholic acid and salts thereof |
| 09/08/2011 | US20110218180 Esters of Capsaicin for Treating Pain |
| 09/08/2011 | US20110218179 Treatment of lupus nephritis using laquinimod |
| 09/08/2011 | US20110218178 Imidazolopyrazine compounds useful for the treatment of degenerative and inflammatory diseases |
| 09/08/2011 | US20110218177 Prodrugs of oxazolidinone cetp inhibitors |
| 09/08/2011 | US20110218176 Compounds, methods, and treatments for abnormal signaling pathways for prenatal and postnatal development |
| 09/08/2011 | US20110218175 Antiviral agents |
| 09/08/2011 | US20110218174 Novel cyclic benzimidazole derivatives useful as anti-diabetic agents |
| 09/08/2011 | US20110218173 Inclusion complexes of pinocembrin with cyclodextrin or its derivatives |
| 09/08/2011 | US20110218172 Composition for down-regulating pro-inflammatory markers |
| 09/08/2011 | US20110218171 Trehalose compound, method for producing same, and pharmaceutical product containing the compound |
| 09/08/2011 | US20110218170 Use of 2'-deoxy-4'-thiocytidine and its analogues as dna hypomethylating anticancer agents |
| 09/08/2011 | US20110218169 Pirfenidone/Toll-Like Receptor (TLR) Agonist Compounds and Methods of Treating Neutropenia |
| 09/08/2011 | US20110218168 Substituted polyamines as inhibitors of bacterial efflux pumps |
| 09/08/2011 | US20110218167 Triterpenoid 2-deoxy Glycosides, Method of Preparation Thereof and Use Thereof as Medicaments |
| 09/08/2011 | US20110218166 Mucoadherents compositions and their use |
| 09/08/2011 | US20110218164 Therapeutic, dietary or cosmetic use of compounds with specific anti-apoptotic activity toward caspase-3, and compositions containing these compounds |
| 09/08/2011 | US20110218163 Paeoniflorin Preparations and Uses Thereof for Fat Reduction |
| 09/08/2011 | US20110218162 15-thia steroid compounds and compositions |
| 09/08/2011 | US20110218161 Cycloastragenol monoglucoside, preparation, pharmaceutical composition and application thereof |
| 09/08/2011 | US20110218160 Arylalkylamine compound and process for preparing the same |
| 09/08/2011 | US20110218159 Methods of using inhibitors of sodium-glucose cotransporters 1 and 2 |
| 09/08/2011 | US20110218158 Dna cytosine deaminase inhibitors |
| 09/08/2011 | US20110218156 Molecular entities for binding, stabilization and cellular delivery of negatively charged molecules |
| 09/08/2011 | US20110218155 Chemical modulators of pro-apoptotic bax and bcl-2 polypeptides |
| 09/08/2011 | US20110218154 Histone deacetylases, and uses related thereto |
| 09/08/2011 | US20110218143 Compositions and methods for tissue repair |
| 09/08/2011 | US20110218142 Inhibitors of Dipeptidylpeptidase IV |
| 09/08/2011 | US20110218140 Biodegradable therapeutic nanoparticles containing an antimicrobial agent |
| 09/08/2011 | US20110218139 Combination therapy and methods for treating bacterial biofilms |
| 09/08/2011 | US20110218107 Use of Propineb for Physiological Curative Treatment Under Zinc Deficiency |
| 09/08/2011 | US20110217401 Aging-Related Circulating Particle-Associated Lipoprotein B Oxidase (apoBNOX) and Inhibitors Thereof |
| 09/08/2011 | US20110217389 Methods for treating heat stress and related compositions |
| 09/08/2011 | US20110217387 Pharmaceutical composition for treatment of fibromyalgia |
| 09/08/2011 | US20110217384 Modified Release Dosage Forms of Skeletal Muscle Relaxants |
| 09/08/2011 | US20110217383 Ph-dependent controlled release pharmaceutical opioid composition with resistance against the influence of ethanol |
| 09/08/2011 | US20110217382 Methods and Compositions for Treating Pain Comprising a Statin |
| 09/08/2011 | US20110217381 Pharmaceutical compositions |
| 09/08/2011 | US20110217379 Magnetic nanomaterials and methods for chemoembolisation |
| 09/08/2011 | US20110217377 Long Circulating Nanoparticles for Sustained Release of Therapeutic Agents |
| 09/08/2011 | US20110217376 Poly(amidoamine) oligomer hydrogel for drug delivery and drug carrier using the same |
| 09/08/2011 | US20110217374 pharmaceutical composition simultaneously having rapid-acting property and long-acting property |
| 09/08/2011 | US20110217373 Extended release pharmaceutical compositions of guanfacine hydrochloride |
| 09/08/2011 | US20110217372 Fast dissolving oral tablets and method for production thereof |
| 09/08/2011 | US20110217371 Controlled-release microparticles and method of preparing same |
| 09/08/2011 | US20110217369 Fenofibrate compositions |
| 09/08/2011 | US20110217367 Means for inhibiting the expression of orc-1 |
| 09/08/2011 | US20110217365 Compositions and Methods for Gene Silencing |
| 09/08/2011 | US20110217364 Conjugated suramin amino compounds for medical conditions |
| 09/08/2011 | US20110217362 Group of Nucleic Acid Fragments for Prevention of HIV Infection or AIDS and the Usage Thereof |
| 09/08/2011 | US20110217361 Group of Nucleic Acid Fragments for Prevention of HIV Infection or AIDS and the Usage Thereof |
| 09/08/2011 | US20110217360 Octenidine composition |
| 09/08/2011 | US20110217359 Pharmaceutical composition for the prophylactic or therapeutic treatment of decubiti and first degree burns and treatment method |
| 09/08/2011 | US20110217357 Method for solubilizing metronidazole |
| 09/08/2011 | US20110217356 Controlled delivery system |
| 09/08/2011 | US20110217354 Implants for administering substances and methods of producing implants |
| 09/08/2011 | US20110217353 Implants for administering substances and methods of producing implants |
| 09/08/2011 | US20110217348 Treated textile material for use in aquatic environments |
| 09/08/2011 | US20110217346 Emulsion containing organosilicon-based portions of hollow spheres |
| 09/08/2011 | US20110217344 Spermicidal and virucidal properties of various forms of sophorolipids |
| 09/08/2011 | US20110217342 Flashmelt oral dosage formulation |
| 09/08/2011 | US20110217341 Method for preparing microspheres and microspheres produced thereby |
| 09/08/2011 | US20110217340 nanodisperse compositions |
| 09/08/2011 | US20110217339 Mucoactive agents for treating a pulmonary disease |
| 09/08/2011 | US20110217337 Bioactive agent for bone tissue engineering |
| 09/08/2011 | US20110217336 Chronotherapeutic dosage forms and methods of treatment using chronotherapy |
| 09/08/2011 | US20110217335 Synthesis of resorcylic acid lactones useful as therapeutic agents |
| 09/08/2011 | US20110217331 Inactivation of Reverse Transcriptases By Azido-diarylpyrimidines |
| 09/08/2011 | US20110217326 Method for diagnosing and/or treating tumor |
| 09/08/2011 | US20110217325 T cell epitopes of the cyn d 1 allergen from bermuda grass pollen |
| 09/08/2011 | US20110217320 Hapten-carrier conjugates for treating and preventing nicotine addiction |
| 09/08/2011 | US20110217316 GBS Toxin Receptor Compositions and Methods of Use |
| 09/08/2011 | US20110217315 Methods and compositions for risk prediction, diagnosis, prognosis, and treatment of pulmonary disorders |